These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24561328)

  • 1. Hepatotoxicity related to agomelatine and other new antidepressants: a case/noncase approach with information from the Portuguese, French, Spanish, and Italian pharmacovigilance systems.
    Montastruc F; Scotto S; Vaz IR; Guerra LN; Escudero A; Sáinz M; Falomir T; Bagheri H; Herdeiro MT; Venegoni M; Montastruc JL; Carvajal A
    J Clin Psychopharmacol; 2014 Jun; 34(3):327-30. PubMed ID: 24561328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity associated with agomelatine and other antidepressants: Disproportionality analysis using pooled pharmacovigilance data from the Uppsala Monitoring Centre.
    Gahr M; Zeiss R; Lang D; Connemann BJ; Schönfeldt-Lecuona C
    J Clin Pharmacol; 2015 Jul; 55(7):768-73. PubMed ID: 25650773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms.
    Gahr M; Zeiss R; Lang D; Connemann BJ; Hiemke C; Schönfeldt-Lecuona C
    J Clin Pharmacol; 2016 Jun; 56(6):769-78. PubMed ID: 26470856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse event profiles of drug-induced liver injury caused by antidepressant drugs: a disproportionality analysis.
    Jiang A; Wei C; Zhu W; Wu F; Wu B
    Ther Adv Drug Saf; 2024; 15():20420986241244585. PubMed ID: 38715707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity associated with the new antidepressants.
    Carvajal García-Pando A; García del Pozo J; Sánchez AS; Velasco MA; Rueda de Castro AM; Lucena MI
    J Clin Psychiatry; 2002 Feb; 63(2):135-7. PubMed ID: 11874214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources.
    Pladevall-Vila M; Pottegård A; Schink T; Reutfors J; Morros R; Poblador-Plou B; Timmer A; Forns J; Hellfritzsch M; Reinders T; Hägg D; Giner-Soriano M; Prados-Torres A; Cainzos-Achirica M; Hallas J; Brandt L; Cortés J; Aguado J; Perlemuter G; Falissard B; Castellsagué J; Jacquot E; Deltour N; Perez-Gutthann S
    CNS Drugs; 2019 Apr; 33(4):383-395. PubMed ID: 30830574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antidepressive agents and hyponatremia: A literature review and a case/non-case study in the French Pharmacovigilance database].
    Rochoy M; Zakhem-Stachera C; Béné J; Berkhout C; Gautier S;
    Therapie; 2018 Oct; 73(5):389-398. PubMed ID: 29773358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agomelatine: a review of adverse effects.
    Prescrire Int; 2013 Mar; 22(136):70-1. PubMed ID: 23593692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of agomelatine: focus on hepatotoxicity.
    Gahr M; Kratzer W; Fuchs M; Connemann BJ
    Curr Drug Metab; 2014; 15(7):694-702. PubMed ID: 25255870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agomelatine and hepatotoxicity: implications of cumulated data derived from spontaneous reports of adverse drug reactions.
    Gahr M; Freudenmann RW; Connemann BJ; Hiemke C; Schönfeldt-Lecuona C
    Pharmacopsychiatry; 2013 Sep; 46(6):214-20. PubMed ID: 23966266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced progressive multifocal leukoencephalopathy: a case/noncase study in the French pharmacovigilance database.
    Colin O; Favrelière S; Quillet A; Neau JP; Houeto JL; Lafay-Chebassier C; Pérault-Pochat MC;
    Fundam Clin Pharmacol; 2017 Apr; 31(2):237-244. PubMed ID: 27736027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems.
    Lapeyre-Mestre M; de Castro AM; Bareille MP; Del Pozo JG; Requejo AA; Arias LM; Montastruc JL; Carvajal A
    Fundam Clin Pharmacol; 2006 Aug; 20(4):391-5. PubMed ID: 16867024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data.
    Wei C; Liu Y; Jiang A; Wu B
    Int J Clin Pharm; 2022 Jun; 44(3):709-716. PubMed ID: 35364753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database.
    Perez-Lloret S; Rey MV; Bondon-Guitton E; Rascol O; Montastruc AJ;
    J Clin Psychopharmacol; 2012 Dec; 32(6):824-7. PubMed ID: 23131889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver injury associated with antidepressants.
    Park SH; Ishino R
    Curr Drug Saf; 2013 Jul; 8(3):207-23. PubMed ID: 23914755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-induced liver injury: a review for clinicians.
    Voican CS; Corruble E; Naveau S; Perlemuter G
    Am J Psychiatry; 2014 Apr; 171(4):404-15. PubMed ID: 24362450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
    Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
    Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone.
    Ye JH; Ho YF; On AW; Chen WW; Huang YM; Huang WI; Tang YW
    Int J Clin Pharm; 2018 Aug; 40(4):911-920. PubMed ID: 30051228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database.
    Pierson-Marchandise M; Gras V; Moragny J; Micallef J; Gaboriau L; Picard S; Choukroun G; Masmoudi K; Liabeuf S;
    Br J Clin Pharmacol; 2017 Jun; 83(6):1341-1349. PubMed ID: 28002877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.